We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > immunotherapies

News List

Pierre Fabre and H-Immune to develop new cancer immunotherapies pharmaceutical-technology
March 23, 2017
French pharmaceutical company Pierre Fabre and H-Immune have entered a strategic research partnership to develop ...
Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board firstwordpharma
March 08, 2017
New Board Members Include Hematology Experts Catherine Bollard, Hervé Dombret, Ola Landgren, Marcela Maus & Dietger Niederweiser
Dr Igor Matushansky Appointed Global Head, Research and Development of Hookipa Biotech b3cnewswire
March 07, 2017
Hookipa Biotech AG, a company pioneering a new class of immunotherapies for oncology and infectious diseases, today announces the appointment of Igor Matushansky, M.D., Ph.D. as Global Head, Research and Development. The appointment is effective from toda
ASLAN collaborates with CSI, NCIS to investigate lead cancer compound biospectrumasia
March 03, 2017
The collaboration is to investigate the potential of ASLAN003 as a monotherapy and in combination with other targeted agents for haematologic cancers.

Previous page 1 2 Next page